Drug intelligence / Profile preview

Bushen Qiangdu Prescription

Development stage
Unknown
Lead developer
China-Japan Friendship Hospital
Administration
Oral
01

Overview

Bushen Qiangdu Prescription (BSQD) is a Traditional Chinese Medicine (TCM) herbal formula developed by the China-Japan Friendship Hospital, specifically within its rheumatology department, for the treatment of ankylosing spondylitis (AS). The prescription is designed based on the TCM principle of "tonifying the kidney and strengthening the Du meridian," which is believed to address the underlying pathogenesis of spinal stiffness and pain in AS patients. It typically comprises a combination of herbs such as Rehmannia glutinosa, Epimedium, and Cibotium barometz. Clinical and preclinical studies suggest that BSQD exerts therapeutic effects by modulating the immune system and reducing the levels of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-17 (IL-17), thereby inhibiting the inflammatory response and potentially slowing radiographic progression in the spine.

Other names
Bushen Qiangdu decoctionBSQDKidney-tonifying and Spine-strengthening PrescriptionKidney Supplementation Formula
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-17A (Interleukin-17A)

Beyond the preview

Go deeper on Bushen Qiangdu Prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bushen Qiangdu Prescription.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call